Increased α-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis

European Journal of Clinical Nutrition

Volumn 58, Issue 7, 2004, Pages 1083-1089

  Bemelmans, W J E ^a,c   Lefrandt, J D ^b   Feskens, E J M ^c   van Haelst, P L ^b   Broer, J ^d   Meyboom de Jong, B ^a   May, J F ^b   Cohen Tervaert, J W ^e   Smit, A J ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d Municipal Health Service   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

linolenic acid; Atherosclerosis; C reactive protein; Inflammation; Linolenic acid

Indexed keywords

ANTIBODY; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LINOLEIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN; MARGARINE; PLACEBO;

ADULT; AGED; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MARKER; DOUBLE BLIND PROCEDURE; FEMALE; FEMORAL ARTERY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ALPHA-LINOLENIC ACID; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; DIETARY FATS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INTERLEUKIN-10; INTERLEUKIN-6; LINOLEIC ACID; MALE; MARGARINE; MIDDLE AGED; RISK FACTORS;

EID: 4043114874     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601938     Document Type: Article

References (30)

1. Bemelmans WJE, Muskiet FAJ, Feskens EJM, Vries de JHM, Broer J, May JF & Meyboom-de Jong B (2000): Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease. Eur. J. Clin. Nutr. 54, 865-871.
2. Bemelmans WJE, Broer J, Feskens EJM, Smit AJ, Muskiet FAJ, Lefrandt JF, Bom VJJ May JF & Meyboom-de Jong B (2002): Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN). Am. J. Clin. Nutr. 75, 221-227.
3. Berry EM (2001): Are diets high in omega-6 polyunsaturated fatty acids unhealthy? Eur. Heart. J. 3(Suppl D), 37-41.
4. De Caterina R & Basta G (2001): n-3 Fatty acids and the inflammatory response-biological background. Eur. Heart J. 3(Suppl D), 42-49.
5. Endres S (1996): n-3 polyunsaturated fatty acids and human cytokine synthesis. Lipids 31(Suppl), 239-242.
6. Freese R, Mutanen V, Valstra LM & Salminen I (1994): Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb. Haemost. 71, 73-77.
7. Gabay C & Kushner I (1999): Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454.
8. Glass CK & Witztum JL (2001): Atherosclerosis. The road ahead. Cell 104, 503-516.
9. de Groot E, Zwinderman AH, van der Steen AFW, Ackerstaff RGA, van Montauban Swijndregt AD, Bom N, Lie KI & Bruschke AVG (1998): Variance components analysis of carotid and femoral intima-media thickness measurements. Ultrasound Med. Biol. 24, 825-832.
10. Hennig B, Meerarani P, Ramadass P, Watkins BA & Toborek M (2000): Fatty acid-mediated activation of vascular endothelial cells. Metabolism 49, 1006-1013.
11. Libby P (2002): Inflammation in atherosclerosis. Nature 420, 868-874.
12. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P & Delaye J (1994): Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454-1459.
13. Ma J, Folsom AR, Lewis L & Eckfeldt JH (1997): Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Clin. Nutr. 65, 551-559.
14. Mantzioris E, Cleland LG, Gibson RA, Neumann MA, Demasi M & James MJ (2000): Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am. J. Clin. Nutr. 72, 42-48.
15. Marchioli R & on behalf of the GISSI-Prevenzione investigators (2001): Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione Trial. Eur. Heart. J. 3(Suppl D), 85-97.
16. National Cholesterol Education Program (2001): Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
17. Pakala R, Pakala R, Sheng WL & Benedict CR (1999): Eicosapentaenoic acid and docosahexaenoic acid block serotonin-induced smooth muscle cell proliferation. Arterioscler. Thromb. Vasc. Biol. 19, 2316-2322.
18. Rallidis LS, Paschos G, Liakos GK, Velissaridou H, Anastasiadis G & Zampelas A (2003): Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167, 237-242.
19. Ridker PM (2003): Clinical application of C-reactive Protein for cardiovascular disease detection and prevention. Circulation 107, 363-369.
20. Ridker PM, Buring JE, Cook NR & Rifai N (2003): C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14.719 initially healthy American women. Circulation 107, 391-397.
21. Ross R (1999): Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126.
22. Sanders TA (2000): Polyunsaturated fatty acids in the food chain in Europe. Am. J. Clin. Nutr. 71(Suppl 1), 176-178.
23. Sanderson P, Finnegan YE, Williams CM, Calder PC, Burdge GC, Wootton SA, Griffin BA, Millward DJ, Pegge NC & Bemelmans WJE (2002 : UK Food Standards Agency alpha-linolenic acid workshop report. Br. J. Nutr. 88, 573-579.
24. von Schacky C (2000): n-3 Fatty acids and the prevention of coronary atherosclerosis. Am. J. Clin. Nutr. 71(Suppl), 224-227.
25. Schaefer J (1997): Effects of dietary fatty acids on lipoproteins and cardiovascular disease risk: summary. Am. J. Clin. Nutr. 65(Suppl 1), 1655-1656.
26. Schmidt EB, Kristensen SB, De Caterina R & Illingworth DR (1993): The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103, 107-121.
27. Swets BP, Brouwer DA & Cohen Tervaert JW (2001): Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin. Exp. Immunol. 124, 163-167.
28. Ubels FL, Terpstra WF & Smit AJ (1999): Carotid intima-media thickness: influence of drug treatment and clinical implications. Neth. J. Med. 55, 188-195.
29. Watts GF, Lewis B, Jackson P, Burke V, Lewis ES, Brunt JN & Coltart DJ (1995): Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Can. J. Cardiol. 11(Suppl G), 110-114.
30. Wolkerstorfer A, Laan MP, Savelkoul HFJ, Neijens HJ, Mulder PG, Oudesluijs-Murphy AM, Sukhai RN & Oranje AP (1998): Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis. Br. J. Dermatol. 138, 431-435.